Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Efavirenz is highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase
3-Nitropropionic acid (3-NPA)
BI 224436 is the first non-catalytic site integrase inhibitor (NCINI)
A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients
XMD17-109 is a potent
Baloxavir marboxil Size:2mg solid Efavirenz is highly specific andBaloxavir marboxil is a novel cap dependent endonuclease inhibitor for the treatment of influenza A and B virus infections. Product information CAS Number: 1985606 14 1 Molecular Weight: 571. 55 Formula: C27H23F2N3O7S Synonym: S 033188 Xofluza Chemical Name: ({(12aR) 12 [(11S) 7, 8 difluoro 6, 11 dihydrodibenzo[b, e]thiepin 11 yl] 6, 8 dioxo 3, 4, 6, 8, 12, 12ahexahydro 1H [1, 4]oxazino[3, 4 c]pyrido[2, 1 f][1, 2, 4]triazin 7 yl}oxy)methyl methyl
US$ 1300.00
US$ 2250.00
US$ 1499.50
US$ 1100.00
US$ 449.50
US$ 41450.00
US$ 2750.00
US$ 4750.00